Latest

Drugmakers will have to show more than efficacy to justify price

Drugmakers will have to show more than efficacy to justify price

The IMS Institute for Healthcare Informatics says makers of cancer drugs will need more than data points for payers to see the value in their pricey new treatments.

Poll: Patients rely on others to help with OTC choices

Poll: Patients rely on others to help with OTC choices

A Pfizer poll shows patients rely on over-the-counter medications but need help finding the right treatment.

Steal this headline. Win an MM&M Award

Steal this headline. Win an MM&M Award

With 13 categories added in the last two years, there are more ways to win than ever. What could be better? We just extended the entry deadline by a week.

Five things for pharma marketers to know: Monday, May 4

Five things for pharma marketers to know: Monday, May 4

Drugmakers engage early with insurers; patients push for implant to be pulled from the market; about one-third of new drugs qualify for special approval pathways

Fit4D wins MM&M shark-tank challenge

Fit4D wins MM&M shark-tank challenge

Four start-ups presented their business models to pharma executives during the MM&M Transforming Healthcare conference on Thursday in New York City.

Five things for pharma marketers to know: Friday, May 1

Five things for pharma marketers to know: Friday, May 1

Nexium tops the list of Medicare's spending on brand drugs; Gilead Sciences doubles its first-quarter profit; Pfizer reportedly wants to buy a rare-disease drug company

Washington Insider: Paul Thacker

Washington Insider: Paul Thacker

Viewpoint: Make Brand Value a Personalized Dialogue

Viewpoint: Make Brand Value a Personalized Dialogue

Well-designed studies can deliver actionable information that optimizes customer engagement

Back Talk: In a Jam? Do the Right Thing

Back Talk: In a Jam? Do the Right Thing

A textbook example of a firm doing the right thing in a crisis: J&J's decisive crisis management saved a brand

Partner Forum: Social for HCPs—Is Now the Time?

The increasing use of social media to reach consumers in the healthcare arena raises questions: Is it time to leverage it for HCPs, and if so, what are the most viable platforms for pharma-HCP communications?

Private View: Elliott Smith

Private View: Elliott Smith

Agency Spotlight


The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.

Email Newsletters